Mark Brosius Sells 2,128 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Mark Brosius also recently made the following trade(s):

• On Thursday, October 24th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $510.79, for a total value of $11,237.38.
• On Thursday, September 12th, Mark Brosius sold 2,115 shares of Intuitive Surgical stock. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $0.95 during trading on Thursday, reaching $511.63. 755,379 shares of the stock traded hands, compared to its average volume of 1,471,841. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $523.34. The company has a 50-day moving average of $486.71 and a 200-day moving average of $440.96. The stock has a market capitalization of $181.48 billion, a P/E ratio of 92.35, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth about $26,000. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. LGT Financial Advisors LLC increased its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares during the last quarter. Finally, Delos Wealth Advisors LLC increased its stake in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.